Evidence map›Paper›PMID 27759917›Full record

ArticleAmerican journal of medical genetics. Part A2017

Implication of LRRC4C and DPP6 in neurodevelopmental disorders.

Gilles Maussion, Cristiana Cruceanu, Jill A Rosenfeld, Scott C Bell, Fabrice Jollant, Jin Szatkiewicz, Ryan L Collins, Carrie Hanscom, Ilaria Kolobova, Nicolas Menjot de Champfleur and 22 more

Open access · greenAbstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Epigenomic and phenotypic characterization of DEGCAGS syndrome.European journal of human genetics : EJHG · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Sensory Gating in Neurodevelopmental Disorders: A Scoping Review.Research on child and adolescent psychopathology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 19 institutions in 5 countries.

Gilles MaussionDepartment of Psychiatry, McGill Group for Suicide Studies, and Douglas Mental Health University Institute, Montreal, Canada.
Cristiana CruceanuDepartment of Psychiatry, McGill Group for Suicide Studies, and Douglas Mental Health University Institute, Montreal, Canada.
Jill A RosenfeldSignature Genomic Laboratories, PerkinElmer, Inc., Spokane, Washington.
Scott C BellDepartment of Psychiatry, McGill Group for Suicide Studies, and Douglas Mental Health University Institute, Montreal, Canada.
Fabrice JollantDepartment of Psychiatry, McGill Group for Suicide Studies, and Douglas Mental Health University Institute, Montreal, Canada.
Jin SzatkiewiczDepartment of Genetics, University of North Carolina, Chapel Hill, North Carolina.
Ryan L CollinsCenter for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts.
Carrie HanscomCenter for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts.
Ilaria KolobovaDepartment of Psychiatry, McGill Group for Suicide Studies, and Douglas Mental Health University Institute, Montreal, Canada.
Nicolas Menjot de ChampfleurDepartment of Neuroradiology, University Hospital Center of Montpellier, Montpellier, France.
Ian BlumenthalCenter for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts.
Colby ChiangDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia.
Vanessa OtaDepartment of Psychiatry, McGill Group for Suicide Studies, and Douglas Mental Health University Institute, Montreal, Canada.
Christina HultmanDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Colm O'DushlaineBroad Institute of MIT and Harvard, Cambridge, Massachusetts.
Steve McCarrollBroad Institute of MIT and Harvard, Cambridge, Massachusetts.
Martin AldaDepartment of Psychiatry Halifax, Dalhousie University, Halifax, Nova Scotia, Canada.
Sebastien JacquemontDepartment of Pediatrics, Sainte-Justine Hospital, University of Montreal, Montreal, Canada.
Zehra OrduluDepartment of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, Massachusetts.
Christian R MarshallThe Centre for Applied Genomics and Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
Melissa T CarterRegional Genetics Program, The Children's Hospital of Eastern Ontario, Ottawa, Canada.
Lisa G ShafferSignature Genomic Laboratories, PerkinElmer, Inc., Spokane, Washington.
Pamela SklarDepartments of Neuroscience, Psychiatry and Genetics and Genome Sciences, Mount Sinai Hospital, New York, New York.
Santhosh GirirajanDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania.
Cynthia C MortonBroad Institute of MIT and Harvard, Cambridge, Massachusetts.
James F GusellaCenter for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts.
Gustavo TureckiDepartment of Psychiatry, McGill Group for Suicide Studies, and Douglas Mental Health University Institute, Montreal, Canada.
Dimitri J StavropoulosGenome Diagnostics, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
Patrick F SullivanDepartment of Genetics, University of North Carolina, Chapel Hill, North Carolina.
Stephen W SchererThe Centre for Applied Genomics and Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
Michael E TalkowskiCenter for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts.
Carl ErnstDepartment of Psychiatry, McGill Group for Suicide Studies, and Douglas Mental Health University Institute, Montreal, Canada.
Douglas Mental Health University Institute · CABroad Institute · USCenter for Human Genetics · USHospital for Sick Children · CAPerkinElmer (United States) · USUniversity of North Carolina at Chapel Hill · USBrigham and Women's Hospital · USCentre Hospitalier Universitaire de Montpellier · FRChildren's Hospital of Eastern Ontario · CADalhousie University · CAJames S. McDonnell Foundation · USKarolinska Institutet · SEMassachusetts General Hospital · USMcGill University · CAMount Sinai Hospital · USPennsylvania State University · USUniversité de Montréal · CAUniversity of Manchester · GBUniversity of Toronto · CA

Funding

RAPID GENE DISCOVERYP01GM061354 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI MORTON, CYNTHIA CASSON · 2001 to 2019
$24.3M
NIGMS NIH HHS P01 GM061354
6 · The paper itself

Abstract

We performed whole-genome sequencing on an individual from a family with variable psychiatric phenotypes that had a sensory processing disorder, apraxia, and autism. The proband harbored a maternally inherited balanced translocation (46,XY,t(11;14)(p12;p12)mat) that disrupted LRRC4C, a member of the highly specialized netrin G family of axon guidance molecules. The proband also inherited a paternally derived chromosomal inversion that disrupted DPP6, a potassium channel interacting protein. Copy Number (CN) analysis in 14,077 cases with neurodevelopmental disorders and 8,960 control subjects revealed that 60% of cases with exonic deletions in LRRC4C had a second clinically recognizable syndrome associated with variable clinical phenotypes, including 16p11.2, 1q44, and 2q33.1 CN syndromes, suggesting LRRC4C deletion variants may be modifiers of neurodevelopmental disorders. In vitro, functional assessments modeling patient deletions in LRRC4C suggest a negative regulatory role of these exons found in the untranslated region of LRRC4C, which has a single, terminal coding exon. These data suggest that the proband's autism may be due to the inheritance of disruptions in both DPP6 and LRRC4C, and may highlight the importance of the netrin G family and potassium channel interacting molecules in neurodevelopmental disorders. © 2016 Wiley Periodicals, Inc.

Indexed as

Genetic Association StudiesPhenotype5' Untranslated RegionsAdolescentAdultApraxiasAutistic DisorderChildChild, PreschoolChromosome BreakpointsChromosome InversionComparative Genomic HybridizationDipeptidyl-Peptidases and Tripeptidyl-PeptidasesDNA Copy Number VariationsFemaleGene Expression5' Untranslated RegionsDipeptidyl-Peptidases and Tripeptidyl-PeptidasesDPP6 protein, humanLRRC4C protein, humanNerve Tissue ProteinsPotassium ChannelsReceptors, Cell SurfaceautismDPP6LRRC4CNetrin Gsensory processing

Identifiers

PMID27759917
PMCPMC5833302
OpenAlexW2534401479

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.